Antiprotozoal Drug -

Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis.

Antiprotozoal drugs are a class of medications specifically designed to treat infections caused by protozoa—single-celled eukaryotic organisms. These drugs are critical for managing diseases that primarily affect tropical and subtropical regions, impacting over annually. Market and Clinical Landscape antiprotozoal drug

Compounds such as Metronidazole , Atovaquone, and Benznidazole continue to lead treatment protocols. Malaria remains the most prevalent, with an estimated